In November 1958, Georges Mathé performed the first successful allogeneic bone marrow transplant between unrelated individuals. This procedure was carried out on four Yugoslav nuclear researchers who had suffered accidental radiation exposure. This landmark event signaled a shift in medical potential, proving that immune systems could be manipulated to treat otherwise lethal conditions like leukemia.
Background and Education
Born in 1922 in the French village of Sermages, Mathé was the child of a rural family. He studied at a boarding school in Moulins, Allier, before participating in the French Resistance during World War II. He subsequently pursued a medical education in Paris, graduating with honors in 1950–51. His early professional development included an internship at the Memorial Sloan–Kettering Cancer Center in New York and specialized training in hematology alongside Paul Chevallier and Jean Bernard.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Advancements in Transplant Science
By 1963, Mathé achieved a significant milestone by announcing the successful treatment of leukemia using bone marrow transplantation. Beyond radiation recovery, his research demonstrated that stem cells could actively combat malignant tumors. His work during the 1960s also included collaborating with René Kuss and Marcel Legrain on the first successful kidney grafts between unrelated donors and recipients.
Institutional Leadership
Mathé directed the Hematology Department at the Institut Gustave Roussy in Villejuif starting in 1961. In 1964, he established the Institut de Cancérologie et d’Immuno-génétique, introducing the first sterile hospital environments. From 1980 to 1988, he managed the Service des Maladies Sanguines et Tumorales at the Hôpital Paul-Brousse. His academic contributions included teaching experimental oncology at the University of Paris from 1966 until 1990.
Pharmacology and International Organizations
His research facilitated the development of critical molecules such as oxaliplatine, vinorelbine, and triptoreline. He co-founded the Groupe Européen de Chimiothérapie Anticancéreuse (GECA) in 1962, serving as its first president until 1965. Additionally, he helped create several major institutions, including the ARC, INSERM, and the European Society for Medical Oncology. He remained an active researcher until his death in 2010 in Villejuif.
Fast facts
- Born: 1922, Sermages, France
- Died: 2010, Villejuif, France
- Education: Medical degree, Paris (1950-51)
- Key achievement: First successful unrelated bone marrow transplant (1958)
- Notable awards: Leopold Griffuel Prize (1994), Medawar Prize (2002)
- Academic appointments: University of Paris (1966-1990)
- Professional memberships: Serbian Academy of Sciences and Arts, Academy of the Kingdom of Morocco
- Final resting place: Sermages, France
Questions readers ask
What medical techniques did Georges Mathé pioneer?
He pioneered allogeneic bone marrow transplantation between unrelated humans and developed the concept of adoptive immunotherapy to treat cancer.
Which pharmaceutical molecules did he help develop?
His work contributed to the development of several important molecules including acriflavine, bestatine, ellipticine, oxaliplatine, triptoreline, and vinorelbine.
Achievements
- Leopold Griffuel Prize — 1994
- Medawar Prize — 2002
- Held posts at French National Institute of Health and Medical Research
- Fields: chemotherapy and immunotherapy
